Filters
Hikma completes acquisition of Teligent sterile injectable assets
Press Release, Corporate
Hikma launches Diazepam Injection, USP in single-dose prefilled syringe
Press Release, Corporate
Hikma signs license agreement with Medicine Patent Pool for molnupiravir
Press Release, Corporate
Hikma Ventures leads Series A extension in NuvoAir to support its platform for patient-centric care and clinical trials
Press Release, Corporate
Hikma expands into Canada with acquisition of Teligent sterile injectable assets
Press Release, Corporate
Hikma to present at 40th Annual J.P. Morgan Healthcare Conference
Press Release, Corporate
Hikma Launches New 503B Sterile Compounding Business
Press Release, Corporate
Hikma launches Bupivacaine HCl Injection, USP
Press Release, Product
Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar ...
Press Release, Product
Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA
Press Release, Corporate
Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to...
Press Release, Corporate
Hikma continues strong 2021 performance and reiterates full year guidance
Press Release, Corporate
Hikma and Almirall enter an exclusive licensing agreement to market Finjuve in the Middle East and North Africa region
Press Release, Product
Hikma donates 50,000 doses of injectable naloxone to help expand non-profit access to lifesaving treatment for reversing...
Press Release, Corporate
Hikma launches Micafungin for Injection
Press Release, Product